Skip to main content
OpenTrials
Completed

NCT Number: NCT01938885

Hepatic Pseudoaneurysms After Trauma

Hepatic pseudoaneurysm (HPA) is a rare complication after liver trauma, yet it is potentially fatal, as it can lead to sudden severe haemorrhage. The risk of developing posttraumatic hepatic pseudoaneurysm is one of the reasons why some trauma centres do follow-up CT of patients with liver injuries to take the therapeutic consequence. The aim of this study was to investigate the occurrence of HPA post liver trauma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–77 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Rigshospitalet

Copenhagen, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • conservatively managed liver trauma patients with follow-up CT or US

Exclusion criteria

  • patients who underwent laparotomy because of other intra-abdominal injuries

Treatment and study plan

Primary outcomes

  1. Incidence and nature of hepatic pseudoaneurysm after hepatic trauma

    Time frame: 2000-2010

    All admitted and conservatively treated patients with sustained lever injury due to trauma from 2000-2010 were reviewed in order to investigate the incidence and nature of hepatic pseudoaneurysms after liver trauma

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

Hepatic Pseudoaneurysms After Conservatively Managed Liver Injuries

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Sep 10, 2013
Registry last updated
Sep 18, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.